PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it will present at Canaccord Adams 28th Annual Global Growth Conference to be held in Boston from August 12-14 at the Intercontinental Boston Hotel.
